0.7580
+0.0347
+(4.80%)
At close: April 17 at 4:00:00 PM EDT
0.7875
+0.03
+(3.89%)
After hours: April 17 at 6:57:32 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-59,145
-59,145
-51,711
-45,806
-39,241
Investing Cash Flow
66,250
66,250
-43,735
-25,740
-138,964
Financing Cash Flow
1,144
1,144
368
562
327,447
End Cash Position
28,648
28,648
20,399
115,477
186,461
Capital Expenditure
-2,122
-2,122
-2,442
-2,324
-2,269
Free Cash Flow
-61,267
-61,267
-54,153
-48,130
-41,510
12/31/2021 - 8/7/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CSJ.BE CSL Ltd
134.60
-1.25%
ZH6.BE Biohaven Ltd. R
17.90
+10.49%
B9A.MU BioArctic AB
15.18
-16.41%
50BA.MU Bicycle Therapeutics PLC
6.80
+3.82%
301080.SZ Acrobiosystems Co.,Ltd.
43.16
+0.14%
CSJ.MU CSL Ltd
134.56
-0.83%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2261
+4.48%
REGN.VI Regeneron Pharmaceuticals, Inc.
490.00
-0.18%
NRIX Nurix Therapeutics, Inc.
10.24
+4.49%
ATRY.MC Atrys Health, S.A.
2.8500
+0.35%